Skip to main content
. 2015 Jun 30;2015(6):CD010037. doi: 10.1002/14651858.CD010037.pub2
Methods Double‐blind randomised placebo‐controlled trial.
The trial was conducted in Denmark.
Participants 28 healthy women with early menopause (6 months to 3 years earlier). Overweight was not an exclusion criterion.
Interventions Intervention group:2000 mg calcium per day (14 participants).
Control group: identical‐looking placebo tablets (14 participants).
Trial duration: 1 year.
Outcomes Blood pressure. BP was measured by mercury manometer after 10 min of supine rest
Notes Tablets were provided by Sandoz
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Participants were allocated into 2 groups according to random sampling numbers
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) All outcomes Low risk Double‐blind, placebo‐controlled trial. Participants received identical‐looking tablets
Blinding of outcome assessment (detection bias) All outcomes Unclear risk Not described
Incomplete outcome data (attrition bias) All outcomes Low risk All participants were evaluated at the end of the study.
Selective reporting (reporting bias) Low risk The primary outcome was reported.
Other bias High risk Placebo participants had higher initial weight and lower systolic blood pressure.